Thrombocytosis - a Marker of Disease Severity in Children with Viral
Respiratory Tract Infections
Abstract
Background: Reactive thrombocytosis (Platelets
>500K/μl) is estimated between 3-13% in hospitalized
children and has been associated with RSV infection and younger age. We
aimed to examine the clinical significance of thrombocytosis in children
admitted to the hospital with an influenza-like illness (ILI).
Methods: We performed an analysis of a database of patients
evaluated at our Medical Centers with an ILI between 2009 and 2013. We
included pediatric patients and examined the association between
platelet count, respiratory viral infections, and admission outcomes
(hospital length of stay (LOS) and admission to the pediatric intensive
care unit (PICU() using regression models adjusting for laboratory,
clinical and demographic parameters. Results: Of 19,192 adults
and children in the database, 5,171 children met inclusion criteria
(median age 0.8 years (Interquartile range, 0.2-1.8), 58% male, median
LOS of 3 days (Interquartile range, 2-5)). Younger age and not the type
of viral infection was associated with a high platelet count
(p<0.001). Elevated platelet count independently predicted
admission outcomes, adjusted for multiple covariates (p≤0.006).
Furthermore, the presence of thrombocytosis was associated with an
increased risk for a prolonged LOS (odds ratio=1.2 (95% Confidence
interval=1.1-1.4, p=0.003)) and admission to the PICU (odds ratio=1.5
(95% Confidence interval =1.1-2.0, p=0.002)). Conclusions: In
children admitted with an ILI, a high platelet count is associated with
younger age and is an independent predictor of hospital LOS and
admission to the PICU. Our results show that platelet count may be used
to improve risk assessment and management decisions in these pediatric
patients.